The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Abstract
Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state. We show that four factors ( OCT4, SOX2, NANOG , and LIN28 ) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells. These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivatives of all three primary germ layers. Such induced pluripotent human cell lines should be useful in the production of new disease models and in drug development, as well as for applications in transplantation medicine, once technical limitations (for example, mutation through viral integration) are eliminated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retro/lentiviruses have enabled genetic approaches in cultured primary cells to ectopically express genes of interest (1–6).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Viral screens using focused overexpression libraries can identify putative reprogramming factors, for example, by identifying a defined set of transcription factors that are selectively required to induce pluripotent stem cells (2–4,7) or trans-differentiate from mature somatic cell into another mature somatic cell (1,8–11).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Despite the power of viral technologies, pooled screens for cell reprogramming have generally adopted a one-by-one elimination approach or testing for exhaustive combinations and interrogating phenotypes in cell culture from transgenic mice (1,3,10) and/or aberrantly cloned cell lines (12).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Successful transformation of human somatic cells into iPSCs was first carried out in 2007 using a lentiviral system [95].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [95]
In the citing paper
“It has been shown that NANOG and LIN28 in combination with SOX2 and OCT4 can reprogram human somatic cells into iPS cells 30 by increasing reprogramming efficiency by 76-fold 60 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [30]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Self-citationThe ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells
Meissner, A., Wernig, M., & Jaenisch, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1335 · Cited by 763
Homologous recombination in human embryonic stem cells
Zwaka, T. P., & Thomson, J. A. (2003) · Nature Biotechnology · doi:10.1038/nbt788 · Cited by 666
Self-citationVodyanik, M. A., Bork, J. A., Thomson, J. A., & Slukvin, I. I. (2005) · Blood · doi:10.1182/blood-2004-04-1649 · Cited by 619
Self-citation
Cited by
Items 701–800 of 1,132
Wu, X., Schmidt, J. A., Avarbock, M. R., Tobias, J. W., Carlson, C. A., Kolon, T. F., Ginsberg, J. P., & Brinster, R. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912432106 · Cited by 203
“In contrast, genes (Nanog, Pou5f1, and Sox2) known to be important for self-renewal and pluripotency of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) were not expressed at high levels or greatly enriched in prepubertal human spermatogonia and mouse gonocytes (Table S4) (35, 36).”
BackgroundStem cells for ischemic brain injury: A critical review
Burns, T. C., Verfaillie, C. M., & Low, W. C. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.22038 · Cited by 207
“Thomson and colleagues (Yu et al., 2007), likewise using human fibroblasts, employed a slightly different combination (Oct4, Sox 2, NANOG, and LIN28) to generate iPS cells, importantly avoiding the proto-oncogene c-myc.”
BackgroundChou, Y.-F., Chen, H.-H., Eijpe, M., Yabuuchi, A., Chenoweth, J. G., Tesar, P., Lu, J., McKay, R. D. G., & Geijsen, N. (2008) · Cell · doi:10.1016/j.cell.2008.08.035 · Cited by 204
“Human IPS cells Somatic cells bFGF, serum, MEF conditioned media All germ layers Not tested (Park et al., 2008; Takahashi et al., 2007; Yu et al., 2007)”
BackgroundHao, J., Daleo, M. A., Murphy, C. K., Yu, P. B., Ho, J. N., Hu, J., Peterson, R. T., Hatzopoulos, A. K., & Hong, C. C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002904 · Cited by 209
“Recent advances in reprogramming adult somatic tissue to generate induced pluripotent stem (iPS) cells, which possess ES-like features, have heightened the expectation for successful regenerative therapies [3–7].”
BackgroundAtala, A. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.10.003 · Cited by 202
Yin, C., Lin, Y., Zhang, X., Chen, Y.-X., Zeng, X., Yue, H.-Y., Hou, J.-L., Deng, X., Zhang, J.-P., Han, Z.-G., et al. (2008) · Hepatology · doi:10.1002/hep.22510 · Cited by 201
Lin28b Is Sufficient to Drive Liver Cancer and Necessary for Its Maintenance in Murine Models
Nguyen, L. H., Robinton, D. A., Seligson, M. T., Wu, L., Li, L., Rakheja, D., Comerford, S. A., Ramezani, S., Sun, X., Parikh, M. S., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.06.018 · Cited by 206
“In cancer, expression of Lin28 in postnatal tissues appears to reactivate programs of embryonic growth and metabolism to drive tumorigenesis (Viswanathan et al., 2009; Yu et al., 2007).”
The therapeutic potential of stem cells
Watt, F. M., & Driskell, R. R. (2010) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2009.0149 · Cited by 195
Glycome Diagnosis of Human Induced Pluripotent Stem Cells Using Lectin Microarray
Tateno, H., Toyota, M., Saito, S., Onuma, Y., Ito, Y., Hiemori, K., Fukumura, M., Matsushima, A., Nakanishi, M., Ohnuma, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.231274 · Cited by 201
Young, M. A., Larson, D. E., Sun, C.-W., George, D. R., Ding, L., Miller, C. A., Lin, L., Pawlik, K. M., Chen, K., Fan, X., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.03.002 · Cited by 197
“Although iPSC lines generally have normal karyotypes (Park et al., 2008; Takahashi et al., 2007; Wernig et al., 2007; Yu et al., 2007), more recent analyses of iPSC genomes suggest that there may be more subtle genetic consequences of reprogramming.”
BackgroundSOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells
Santini, R., Pietrobono, S., Pandolfi, S., Montagnani, V, D'Amico, M., Penachioni, J. Y., Vinci, M. C., Borgognoni, L., & Stecca, B. (2014) · Oncogene · doi:10.1038/onc.2014.71 · Cited by 201
Mesenchymal Stem Cells for Bone Repair and Metabolic Bone Diseases
Undale, A. H., Westendorf, J. J., Yaszemski, M. J., & Khosla, S. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.10.893 · Cited by 202
Thornton, J. E., Chang, H.-M., Piskounova, E., & Gregory, R. I. (2012) · RNA · doi:10.1261/rna.034538.112 · Cited by 206
“Lin28 overexpression or let-7 inhibition with antisense RNAs promotes reprogramming of human and mouse fibroblasts to induced pluripotent stem cells (iPSCs) (Ambros and Horvitz 1984; Yu et al. 2007; Melton et al. 2010).”
BackgroundDeficits in human trisomy 21 iPSCs and neurons
Weick, J. P., Held, D. L., Bonadurer, G. F., Doers, M. E., Liu, Y., Maguire, C., Clark, A., Knackert, J. A., Molinarolo, K., Musser, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216575110 · Cited by 205
“Three Ts21 iPSC lines (DS1, DS4, and 2DS3) and two euploid iPSC lines (DS2U and IMR90-4) (58) were used in each experiment in this study. iPSCs were maintained and differentiated according to previously established methods (59–61) (SI Materials and Methods, Table S1).”
MethodEmbryonic and adult stem cell therapy
Brignier, A. C., & Gewirtz, A. M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.032 · Cited by 199
Zeng, H., Guo, M., Martins-Taylor, K., Wang, X., Zhang, Z., Park, J. W., Zhan, S., Kronenberg, M. S., Lichtler, A., Liu, H.-X., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011853 · Cited by 198
“The breakthroughs in generation of induced pluripotent stem cell (iPSC) via somatic cell reprogramming[22,23,24,25] have made it possible to obtain human iPSC (hiPSC) from patients such as those with Parkinson disease[26] and amyotrophic lateral sclerosis[27].”
BackgroundMethodSmall-molecule displacement of a cryptic degron causes conditional protein degradation
Bonger, K. M., Chen, L.-C., Liu, C. W., & Wandless, T. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.598 · Cited by 206
“20,21 The genes encoding each transcription factor were tagged at their 3 ′ -ends with DNA encoding the LID domain.”
Dental pulp and dentin tissue engineering and regeneration advancement and challenge
Huang, G. T.-J. (2011) · Frontiers in Bioscience · doi:10.2741/e286 · Cited by 199
“Ultimately, the paucity of postnatal stem cells may be resolved by the generation of induced pluripotent (iPS) cells from somatic cells (95, 96) or from dental stem cells (97).”
BackgroundTFCat: the curated catalog of mouse and human transcription factors
Fulton, D. L., Sundararajan, S., Badis, G., Hughes, T. R., Wasserman, W. W., Roach, J. C., & Sladek, R. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r29 · Cited by 189
“Recent ground-breaking stem cell studies [49,50] have shown the central role of TFs in regulating stem cell pluripotency and differentiation.”
BackgroundChen, T., Shen, L., Yu, J., Wan, H., Guo, A., Chen, J., Long, Y., Zhao, J., & Pei, G. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00722.x · Cited by 204
“…using transiently expressed reprogramming factors in different combinations (Takahashi & Yamanaka, 2006; Meissner et al., 2007; Wer- nig et al., 2007; Yu et al., 2007; Nakagawa et al., 2008), a large number of groups reported studies on reprogramming efficiency as well as some molecular mechanisms…”
BackgroundSelf-citationPolyglutamine (PolyQ) Diseases: Genetics to Treatments
Fan, H.-C., Ho, L.-I., Chi, C.-S., Chen, S.-J., Peng, G.-S., Chan, T.-M., Lin, S.-Z., & Harn, H.-J. (2014) · Cell Transplantation · doi:10.3727/096368914x678454 · Cited by 192
In vitro Modeling of Ryanodine Receptor 2 Dysfunction Using Human Induced Pluripotent Stem Cells
Fatima, A., Xu, G., Shao, K., Papadopoulos, S., Lehmann, M., Arnáiz-Cot, J. J., Rosa, A. O., Nguemo, F., Matzkies, M., Dittmann, S., et al. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335753 · Cited by 193
Jang, J., Wang, Y., Kim, H.-S., Lalli, M. A., & Kosik, K. S. (2014) · Stem Cells · doi:10.1002/stem.1764 · Cited by 198
“First, we found that hESCs (H1 and H9 cell lines) and iPS-IMR90 [18] induced pluripotent stem cells had high levels of Nrf2 protein that decreased sharply after 8 days of differentiation by removal of FGF2 (Fig.”
Zhang, X., Neganova, I., Przyborski, S., Yang, C., Cooke, M., Atkinson, S. P., Anyfantis, G., Fenyk, S., Keith, W. N., Hoare, S. F., et al. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200801009 · Cited by 197
“The identity of endoderm, ectoderm, and mesoderm tissues within the tumors was confi rmed by suggesting an important role for each of these factors in reprogramming the genome of somatic cells ( Yu et al., 2007 ).”
Ema, M., Mori, D., Niwa, H., Hasegawa, Y., Yamanaka, Y., Hitoshi, S., Mimura, J., Kawabe, Y.-I., Hosoya, T., Morita, M., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.09.003 · Cited by 198
“Ce DNA methylation, and chromatin status (Yu et al., 2007), they may prove a valuable resource for autologous transplantation instead of ESCs (Hanna et al.”
BackgroundPluripotent Stem Cells Derived From Adult Human Testes
Golestaneh, N., Kokkinaki, M., Pant, D., Jiang, J., DeStefano, D., Fernandez-Bueno, C., Rone, J. D., Haddad, B. R., Gallicano, G. I., & Dym, M. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0347 · Cited by 202
Induction and Isolation of Vascular Cells From Human Induced Pluripotent Stem Cells—Brief Report
Taura, D., Sone, M., Homma, K., Oyamada, N., Takahashi, K., Tamura, N., Yamanaka, S., & Nakao, K. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.182162 · Cited by 200
Cell-based therapy technology classifications and translational challenges
Mount, N. M., Ward, S. J., Kefalas, P., & Hyllner, J. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0017 · Cited by 195
“Recently, the field has further evolved in a disruptive manner with the discoveries of mouse and human induced pluripotent stem (IPS) cells [38–40] and the process of transdifferentiation, i.”
BackgroundHu, Q., Friedrich, A. M., Johnson, L. V., & Clegg, D. O. (2010) · Stem Cells · doi:10.1002/stem.531 · Cited by 193
Bellin, M., Casini, S., Davis, R. P., D'Aniello, C., Haas, J., Ward-van Oostwaard, D., Tertoolen, L. G. J., Jung, C. B., Elliott, D. A., Welling, A., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.240 · Cited by 196
“Human induced pluripotent stem cells (hiPSCs) (Takahashi et al , 2007b; Yu et al , 2007) are creating exciting new opportunities for biomedical research by providing platforms to study mechanisms of genetic disease pathogenesis that could lead to new therapies or reveal drug sensitivities (Braam et…”
Ji, J., Ng, S. H., Sharma, V., Neculai, D., Hussein, S., Sam, M., Trinh, Q., Church, G. M., Mcpherson, J. D., Nagy, A., et al. (2012) · STEM CELLS · doi:10.1002/stem.1011 · Cited by 193
Leon, G., MacDonagh, L., Finn, S. P., Cuffe, S., & Barr, M. P. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.12.001 · Cited by 198
van Schaijik, B., Davis, P. F., Wickremesekera, A. C., Tan, S. T., & Itinteang, T. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204815 · Cited by 196
Advances in regenerative therapy: A review of the literature and future directions
Ntege, E. H., Sunami, H., & Shimizu, Y. (2020) · Regenerative Therapy · doi:10.1016/j.reth.2020.01.004 · Cited by 194
“The Nobel laureate Yamanaka and his group were the first to successfully reprogram mouse embryonic fibroblast cells in 2006 [29], a year later human skin fibroblast derived iPS cells were reported [31,48,50], prior to the use of peripheral blood mononuclear cells as a tissue source [49].”
BackgroundInfluentialModeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure
Chen, X., Sun, G., Tian, E., Zhang, M., Davtyan, H., Beach, T. G., Reiman, E. M., Blurton‐Jones, M., Holtzman, D. M., & Shi, Y. (2021) · Advanced Science · doi:10.1002/advs.202101462 · Cited by 200
Shao, H., Xi, L., Raffeld, M., Feldman, A. L., Ketterling, R. P., Knudson, R., Rodriguez-Canales, J., Hanson, J., Pittaluga, S., & Jaffe, E. S. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.102 · Cited by 197
Ronin Is Essential for Embryogenesis and the Pluripotency of Mouse Embryonic Stem Cells
Dejosez, M., Krumenacker, J. S., Zitur, L. J., Passeri, M., Chu, L.-F., Songyang, Z., Thomson, J. A., & Zwaka, T. P. (2008) · Cell · doi:10.1016/j.cell.2008.05.047 · Cited by 200
“…pluripotent stem, or iPS, cells) by manipulation of several key transcription factors (Takahashi and Yamanaka, 2006; Maherali et al., 2007; Okita et al., 2007; Takahashi et al., 2007; Wernig et al., 2007; Yu et al., 2007), the precise molecular mechanisms that underlie pluripotency remain elusive.”
Self-citationXu, B., Zhang, K., & Huang, Y. (2009) · RNA · doi:10.1261/rna.1368009 · Cited by 194
“The functional significance of Lin28 is further highlighted by its ability to enhance the efficiency in reprogramming human fibroblasts to pluripotency (Yu et al. 2007).”
BackgroundA human liver organoid screening platform for DILI risk prediction
Zhang, C. J., Meyer, S. R., O’Meara, M. J., Huang, S., Capeling, M. M., Ferrer-Torres, D., Childs, C. J., Spence, J. R., Fontana, R. J., & Sexton, J. Z. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.01.019 · Cited by 191
Pluripotency and nuclear reprogramming
Yamanaka, S. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.2261 · Cited by 190
Kawamura, M., Miyagawa, S., Fukushima, S., Saito, A., Miki, K., Ito, E., Sougawa, N., Kawamura, T., Daimon, T., Shimizu, T., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000366 · Cited by 199
“Human induced pluripotent stem (hiPS) cells are initially established by nuclear reprogramming of somatic cells.(5,6) hiPS cell carries a capacity of unlimited proliferation and differentiation to cardiomyocyte.”
BackgroundYAP Induces Human Naive Pluripotency
Qin, H., Hejna, M., Liu, Y., Percharde, M., Wossidlo, M., Blouin, L., Durruthy-Durruthy, J., Wong, P., Qi, Z., Yu, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.036 · Cited by 197
“Human pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), can be propagated almost indefinitely and can give rise to all cell types of the body (Takahashi and Yamanaka, 2006; Takahashi et al., 2007; Thomson et al., 1998; Yu et al., 2007).”
BackgroundSelf-citationOpportunities and challenges of pluripotent stem cell neurodegenerative disease models
Sandoe, J., & Eggan, K. (2013) · Nature Neuroscience · doi:10.1038/nn.3425 · Cited by 191
Transcriptional regulation of Oct4 by a long non-coding RNA antisense to Oct4-pseudogene 5
Hawkins, P. G., & Morris, K. V. (2010) · Transcription · doi:10.4161/trns.1.3.13332 · Cited by 196
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
Lengerke, C., Fehm, T., Kurth, R., Neubauer, H., Scheble, V., Müller, F., Schneider, F., Petersen, K., Wallwiener, D., Kanz, L., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-42 · Cited by 194
“More recently, combinatorial overexpression of OCT4, SOX2, NANOG and others was shown to reprogram several types of adult somatic cells to a pluripotent stem cell like state [17,27,28].”
Deterministic HOX Patterning in Human Pluripotent Stem Cell-Derived Neuroectoderm
Lippmann, E. S., Williams, C. E., Ruhl, D. A., Estevez-Silva, M. C., Chapman, E. R., Coon, J. J., & Ashton, R. S. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.02.018 · Cited by 196
“H9 hESCs (Thomson et al., 1998) (passage 25–45), H9 ishcat2 hESCs (Lian et al., 2012) (passage 33–43), and IMR90-4 iPSCs (Yu et al., 2007) (passage 31–40) were maintained in E8 medium Stem on Matrigel (BD Biosciences) as previously described (Lippmann et al., 2014).”
BackgroundHazeltine, L. B., Simmons, C. S., Salick, M. R., Lian, X., Badur, M. G., Han, W., Delgado, S. M., Wakatsuki, T., Crone, W. C., Pruitt, B. L., et al. (2012) · International Journal of Cell Biology · doi:10.1155/2012/508294 · Cited by 182
“Human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) [5] and human induced pluripotent stem cells (hiPSCs) [6, 7], o ff er the potential to produce an unlimited number of cardiomyocytes for tissue engineering and other applications, due to their capacity for unlimited…”
Kamei, K.-I., Mashimo, Y., Koyama, Y., Fockenberg, C., Nakashima, M., Nakajima, M., Li, J., & Chen, Y. (2015) · Biomedical Microdevices · doi:10.1007/s10544-015-9928-y · Cited by 196
Nagaoka, M., Si-Tayeb, K., Akaike, T., & Duncan, S. A. (2010) · BMC Developmental Biology · doi:10.1186/1471-213x-10-60 · Cited by 193
“The generation of human iPS cells used in the current manuscript have been described in detail elsewhere [23] following the procedures established by Yu et al[3].”
BackgroundMethodAgarwal, P., Zhao, S., Bielecki, P., Rao, W., Choi, J. K., Zhao, Y., Yu, J., Zhang, W., & He, X. (2013) · Lab on a Chip · doi:10.1039/c3lc50678a · Cited by 190
Self-citationStem Cell Therapy for Vascular Regeneration: Adult, Embryonic, and Induced Pluripotent Stem Cells
Leeper, N. J., Hunter, A. L., & Cooke, J. P. (2010) · Circulation · doi:10.1161/circulationaha.109.881441 · Cited by 195
Calcium Handling in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes
Itzhaki, I., Rapoport, S., Huber, I., Mizrahi, I., Zwi-Dantsis, L., Arbel, G., Schiller, J., & Gepstein, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018037 · Cited by 187
“The ability to derive hiPSCs by reprogramming of adult human fibroblasts [2,3] coupled with the capability to coax the differentiation of the generated hiPSCs into the cardiac lineage [6,7,8] opens unique opportunities for basic and translational cardiovascular research.”
BackgroundSwaney, D. L., Wenger, C. D., Thomson, J. A., & Coon, J. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811964106 · Cited by 190
“Recently, adult human cell lines were reprogrammed to an ES cell state (induced pluripotent stem cells, iPS cells) (40, 41).”
BackgroundSelf-citationConcise Review: Human Embryonic Stem Cells—What Have We Done? What Are We Doing? Where Are We Going?
Ilic, D., & Ogilvie, C. (2017) · Stem Cells · doi:10.1002/stem.2450 · Cited by 179
Song, B., Cha, Y., Ko, S., Jeon, J., Lee, N., Seo, H., Park, K.-J., Lee, I.-H., Lopes, C., Feitosa, M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130767 · Cited by 189
“Yamanaka’s and two other groups subsequently accomplished this feat with human somatic cells, reprograming them into human iPSCs (hiPSCs) (9-11), offering the possibility of generating patient-specific stem cells.”
BackgroundMolecular events in neuroendocrine prostate cancer development
Wang, Y., Wang, Y., Ci, X., Choi, S. Y. C., Crea, F., Lin, D., & Wang, Y. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00490-0 · Cited by 182
Historical origins of transdifferentiation and reprogramming
Graf, T. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.11.012 · Cited by 194
REST Regulates Distinct Transcriptional Networks in Embryonic and Neural Stem Cells
Johnson, R., Teh, C. H.-L., Kunarso, G., Wong, K. Y., Srinivasan, G., Cooper, M. L., Volta, M., Chan, S. S.-L., Lipovich, L., Pollard, S. M., et al. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060256 · Cited by 189
“Furthermore, expression of Zfp206, Zfp281, and Lin28 was induced by DN:REST (Figure S14).”
BackgroundInfluentialArticular cartilage tissue engineering: TODAY’S RESEARCH, TOMORROW’S PRACTICE?
Getgood, A., Brooks, R., Fortier, L., & Rushton, N. (2009) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.91b5.21832 · Cited by 191
The potential and limitations of induced pluripotent stem cells to achieve wound healing
Gorecka, J., Kostiuk, V., Fereydooni, A., Gonzalez, L., Luo, J., Dash, B., Isaji, T., Ono, S., Liu, S., Lee, S. R., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1185-1 · Cited by 182
Reprogramming Cellular Identity for Regenerative Medicine
Cherry, A. B. C., & Daley, G. Q. (2012) · Cell · doi:10.1016/j.cell.2012.02.031 · Cited by 191
Stem cell bioprocessing: fundamentals and principles
Placzek, M. R., Chung, I.-M., Macedo, H. M., Ismail, S., Mortera Blanco, T., Lim, M., Min Cha, J., Fauzi, I., Kang, Y., Yeo, D. C. L., et al. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2008.0442 · Cited by 187
Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells
Liao, J.-L., Yu, J., Huang, K., Hu, J., Diemer, T., Ma, Z., Dvash, T., Yang, X.-J., Travis, G. H., Williams, D. S., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq341 · Cited by 190
“HiPSCs have the added advantage of avoiding immunological complications and ethical controversies that are typically associated with handling hESCs (10).”
BackgroundSelf-citationHuman Models Are Needed for Studying Human Neurodevelopmental Disorders
Zhao, X., & Bhattacharyya, A. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.10.009 · Cited by 192
Cai, J., Li, W., Su, H., Qin, D., Yang, J., Zhu, F., Xu, J., He, W., Guo, X., Labuda, K., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.086389 · Cited by 184
Clone- and Gene-Specific Aberrations of Parental Imprinting in Human Induced Pluripotent Stem Cells
Pick, M., Stelzer, Y., Bar-Nur, O., Mayshar, Y., Eden, A., & Benvenisty, N. (2009) · Stem Cells · doi:10.1002/stem.205 · Cited by 182
Induced pluripotent stem cells: at the heart of cardiovascular precision medicine
Chen, I. Y., Matsa, E., & Wu, J. C. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.36 · Cited by 191
Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency
Studer, L., Vera, E., & Cornacchia, D. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.05.004 · Cited by 187
“The discovery of induced PSCs (iPSCs) (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007) was the realization of a longstanding dream in biology, namely to access pluripotency starting from somatic cells of an adult organism.”
BackgroundPeng, S., Chen, L.-L., Lei, X.-X., Yang, L., Lin, H., Carmichael, G. G., & Huang, Y. (2011) · Stem Cells · doi:10.1002/stem.591 · Cited by 190
Totipotency: What It Is and What It Is Not
Condic, M. L. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0364 · Cited by 169
“Confusions Regarding Totipotency in the Non-scientific Literature: Reprogramming ‘‘Too Far’’ Since the advent of cellular reprogramming [109–111], the concern that embryos might be inadvertently generated during reprogramming [112] has frequently been raised, with authors asking, for example, ‘‘how…”
Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming
Li, W., & Ding, S. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.10.002 · Cited by 191
Schmidt, B. Z., Lehmann, M., Gutbier, S., Nembo, E., Noel, S., Smirnova, L., Forsby, A., Hescheler, J., Avci, H. X., Hartung, T., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1805-9 · Cited by 182
MYCN Function in Neuroblastoma Development
Otte, J., Dyberg, C., Pepich, A., & Johnsen, J. I. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.624079 · Cited by 179
“Lin28b, as one example, has been a part of the pluripotency factors first used in reprogramming of human somatic cells that did not depend on the enforced overexpression of MYC (106).”
BackgroundProspective Review of Mesenchymal Stem Cells Differentiation into Osteoblasts
Garg, P., Mazur, M. M., Buck, A. C., Wandtke, M. E., Liu, J., & Ebraheim, N. A. (2017) · Orthopaedic Surgery · doi:10.1111/os.12304 · Cited by 190
Generating a Non-Integrating Human Induced Pluripotent Stem Cell Bank from Urine-Derived Cells
Xue, Y., Cai, X., Wang, L., Liao, B., Zhang, H., Shan, Y., Chen, Q., Zhou, T., Li, X., Hou, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070573 · Cited by 183
“To date, human iPS cells had been successfully generated from different tissue sources, such as skin fibroblasts [2,3], extra-embryonic tissues [4] and blood cells [5], although the reprogramming efficiencies varied much for different cell types.”
BackgroundPhosphoproteomic Analysis of Human Embryonic Stem Cells
Brill, L. M., Xiong, W., Lee, K.-B., Ficarro, S. B., Crain, A., Xu, Y., Terskikh, A., Snyder, E. Y., & Ding, S. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.06.002 · Cited by 189
“Transcription factors can reprogram differentiated cell types to ESC-like cells when ectopically expressed (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007) and were the most abundant known phosphoprotein category (Figures 2G–2I).”
Hollmann, E. K., Bailey, A. K., Potharazu, A. V., Neely, M. D., Bowman, A. B., & Lippmann, E. S. (2017) · Fluids and Barriers of the CNS · doi:10.1186/s12987-017-0059-0 · Cited by 189
“Maintenance of iPSCs Cell lines used were IMR90-4 iPSCs [32], CD12 iPSCs [33], CC3 iPSCs [34], and SM14 iPSCs [35, 36].”
Kokkinaki, M., Sahibzada, N., & Golestaneh, N. (2011) · Stem Cells · doi:10.1002/stem.635 · Cited by 180
“We tested two of our own hiPS cell lines (iPS10 and iPS11) that were both generated from skin fibroblasts of the same male donor using the four Yamanaka retroviral vectors for reprogramming [2], and also the iPS cell line IMR90-4 (WiCell)[29].”
MethodHydrogels for Cardiac Tissue Engineering
Li, Z., & Guan, J. (2011) · Polymers · doi:10.3390/polym3020740 · Cited by 184
“The iPSCs are generated by transfecting four genes into skin fibroblasts [73,74].”
BackgroundLiu, X., Huang, J., Chen, T., Wang, Y., Xin, S., Li, J., Pei, G., & Kang, J. (2008) · Cell Research · doi:10.1038/cr.2008.309 · Cited by 181
Chen, S.-J., Chang, C.-M., Tsai, S.-K., Chang, Y.-L., Chou, S.-J., Huang, S.-S., Tai, L.-K., Chen, Y.-C., Ku, H.-H., Li, H.-Y., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0452 · Cited by 187
“…proliferative abilities, surface antigens, gene expression, epigenetic status of pluripotent cell-specifi c genes, and telomerase activity [ 9 , 10 ]. iPS cells share the same features as ES cells and are capable of self-renewal and differentiation into three germ layers, offering potential…”
Origins and Fates of Cardiovascular Progenitor Cells
Wu, S. M., Chien, K. R., & Mummery, C. (2008) · Cell · doi:10.1016/j.cell.2008.02.002 · Cited by 184
“Extremely exciting, however, is the recent demonstration that human skin fibroblasts can be converted to human ES cell-like cells (Takahashi et al., 2007; Yu et al., 2007).”
BackgroundThe Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness
Ma, Y., Shen, N., Wicha, M. S., & Luo, M. (2021) · Cells · doi:10.3390/cells10092415 · Cited by 181
Bilousova, G., Jun, D. H., King, K. B., De Langhe, S., Chick, W. S., Torchia, E. C., Chow, K. S., Klemm, D. J., Roop, D. R., & Majka, S. M. (2011) · Stem Cells · doi:10.1002/stem.566 · Cited by 185
Wang, D., Quan, Y., Yan, Q., Morales, J. E., & Wetsel, R. A. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0049 · Cited by 180
Streckfuss-Bömeke, K., Wolf, F., Azizian, A., Stauske, M., Tiburcy, M., Wagner, S., Hübscher, D., Dressel, R., Chen, S., Jende, J., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs203 · Cited by 183
“Up to now, reprogramming of human somatic cells was mainly focused on using foetal, neonatal, or adult fibroblasts.(1,2,12,13) The use of human dermal fibroblasts and foreskin or hair keratinocytes for generating hiPSCs shows great promise in clinical application because they are the most accessible cell sources.”
BackgroundWang, J., Zibetti, C., Shang, P., Sripathi, S. R., Zhang, P., Cano, M., Hoang, T., Xia, S., Ji, H., Merbs, S. L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03856-y · Cited by 185
Mallanna, S. K., & Rizzino, A. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.05.014 · Cited by 180
“Other combinations, such as Sox2, Oct4, Lin28 and Nanog, have also been used to generate iPS cells (Yu et al., 2007).”
BackgroundBalzer, E., Heine, C., Jiang, Q., Lee, V. M., & Moss, E. G. (2010) · Development · doi:10.1242/dev.042895 · Cited by 185
“LIN28 is one of a small set of proteins, and the only one that is not a transcription factor, whose activities when combined efficiently generate induced pluripotent stem (iPS) cells from differentiated cells (Yu et al., 2007).”
BackgroundValamehr, B., Robinson, M., Abujarour, R., Rezner, B., Vranceanu, F., Le, T., Medcalf, A., Lee, T. T., Fitch, M., Robbins, D., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.01.014 · Cited by 180
“hiPSCs were first generated by the ectopic expression of multiple genes introduced through genome-integrating retro- and lentiviral expression systems: namely OCT4 (POU5F1), SOX2, cMYC,KLF4, LIN28, andNANOG (Takahashi et al., 2007; Yu et al., 2007).”
BackgroundHypoxic Tumor Microenvironment and Cancer Cell Differentiation
Kim, Y., Lin, Q., Glazer, P., & Yun, Z. (2009) · Current Molecular Medicine · doi:10.2174/156652409788167113 · Cited by 183
Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells
Kidder, B. L., Yang, J., & Palmer, S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003932 · Cited by 184
“Additionally, overexpression of four transcription factors (Oct4, Sox2, Klf4, and c-Myc) is sufficient to reprogram mouse embryonic fibroblasts (MEFs) [12] and human fibroblasts [13–15] to a pluripotent state (iPS cells).”
BackgroundTaura, D., Noguchi, M., Sone, M., Hosoda, K., Mori, E., Okada, Y., Takahashi, K., Homma, K., Oyamada, N., Inuzuka, M., et al. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.02.031 · Cited by 174
“kyotogenerated by introducing four transcription factors (Oct3/4, Sox2, Klf4 and c-Myc) into mouse skin fibroblasts [6], and soon thereafter iPS cells were also generated from human skin fibroblasts [7,8].”
BackgroundShort-Term Immunosuppression Promotes Engraftment of Embryonic and Induced Pluripotent Stem Cells
Pearl, J. I., Lee, A. S., Leveson-Gower, D. B., Sun, N., Ghosh, Z., Lan, F., Ransohoff, J., Negrin, R. S., Davis, M. M., & Wu, J. C. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.01.012 · Cited by 182
“…blockade For regenerative medicine purposes, an alternative source of pluripotent cells is human induced pluripotent stem cells (hiPSC). hiPSCs can be generated by delivering transcription factors to reprogram somatic cells towards a state of pluripotency (Takahashi et al., 2007; Yu et al., 2007).”
BackgroundStudying human nociceptors: from fundamentals to clinic
Middleton, S. J., Barry, A. M., Comini, M., Li, Y., Ray, P. R., Shiers, S., Themistocleous, A. C., Uhelski, M. L., Yang, X., Dougherty, P. M., et al. (2021) · Brain · doi:10.1093/brain/awab048 · Cited by 173
Hester, M. E., Murtha, M. J., Song, S., Rao, M., Miranda, C. J., Meyer, K., Tian, J., Boulting, G., Schaffer, D. V., Zhu, M. X., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.135 · Cited by 183
let‐7 and miR‐17‐92: Small‐sized major players in lung cancer development
Osada, H., & Takahashi, T. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2010.01707.x · Cited by 180
Cell signaling during development of Dictyostelium
Loomis, W. F. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.04.001 · Cited by 180
“It is now possible to convert mature human cells into induced pluripotent stem cells (iPSCs) by providing a cocktail of 4 stem cell associated transcription factors (Yu et al., 2007; Takahashi et al., 2007).”
BackgroundHuman and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells
Sugii, S., Kida, Y., Kawamura, T., Suzuki, J., Vassena, R., Yin, Y.-Q., Lutz, M. K., Berggren, W. T., Izpisúa Belmonte, J. C., & Evans, R. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910172106 · Cited by 179
Role of Mechanical Factors in Fate Decisions of Stem Cells
Li, D., Zhou, J., Chowdhury, F., Cheng, J., Wang, N., & Wang, F. (2011) · Regenerative Medicine · doi:10.2217/rme.11.2 · Cited by 181
Metadata
- Authors
- Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., & Thomson, J. A.
- Affiliations
- WiCell (US)
- Genome Center of Wisconsin, Madison, WI 53706–1580, USA.
- Venue
- Science
- Published
- 2007-12-21
- Volume
- 318
- Issue
- 5858
- Pages
- 1917-1920
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2142046859
- Cited by
- 10,310
- References
- 14
- Citations by year
- 2026: 167 · 2025: 219 · 2024: 285 · 2023: 322 · 2022: 332 · 2021: 506 · 2020: 441 · 2019: 443 · 2018: 452 · 2017: 515 · 2016: 580 · 2015: 652 · 2014: 692 · 2013: 816 · 2012: 940
- FWCI
- 271.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (P20GM069981)
- National Center for Research Resources (P51RR000167)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, somatic cell nuclear transfer, reprogramming factors, Oct4, SOX2, Nanog, Lin28, pluripotency, telomerase activity, germ layer differentiation, karyotype, disease models, drug development, transplantation medicine
- MeSH terms
- Nanog Homeobox Protein, Animals, Cell Differentiation, Cell Line, DNA-Binding Proteins, Fetus, Fibroblasts, Humans, Infant, Newborn, Karyotyping, Teratoma, Transcription Factors, Transduction, Genetic, Mice, SCID, RNA-Binding Proteins, Homeodomain Proteins, Transgenes, Oligonucleotide Array Sequence Analysis, HMGB Proteins, Stem Cell Transplantation, Pluripotent Stem Cells, Cell Shape, Cell Proliferation, Octamer Transcription Factor-3, Mice, Embryonic Stem Cells, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.